Weight loss is a critical factor to reduce inflammation
The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
BACKGROUND Chronic inflammation is a process sustained by the augmentation of circulating cytokines level and C-reactive protein (CRP). Adipocytes and adipose tissue infiltration with inflammatory cells, are an important source of adipokines production, and their expansion due to overnutrition is responsible for increased in inflammation. The reduction of body fat following both controlled diets or gastric surgery can be favorable in the reduction of pro-inflammatory cytokines. METHODS A systematic literature search performed using PubMed, Google Scholar and Cochrane Library database screened for clinical and randomized controlled trials (RCTs) using the combination of the following keywords: "weight loss, inflammation," "restricted diet, anti-inflammatory effect." Studies including diet intervention, weight loss after gastric surgery have been included. Multidisciplinary program with the addition of food supplements, exercise, or drugs have been excluded to avoid their interference with the regulation inflammatory markers. RESULTS Out of 967 articles found, 76 were selected, including a total of 6742 patients with a mean age of 44.0 ± 3,3 years and a BMI of 33 ± 6.6. The observation period ranged from 3 weeks up to two years with an average weight loss per month of 1.1 kg. In most of the studies, it was found that weight loss caused a significant reduction of plasma level of inflammatory cytokines although three studies did not see any effect. CONCLUSIONS In obese and overweight subjects weight loss, induced both by energy-restricted diet or surgery, is a determinant factor for reducing the level of pro-inflammatory markers. Hypocaloric diet has an anti-inflammatory effect independent of the diet composition which can play an important role in the prevention of chronic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 3×
“Physiological mitochondrial production of ROS in WAT promotes adipocytes differentiation [140] and modulates adipocyte apolipoprotein E (apoE) production, which has the function to facilitate lipid flux [141].”
BackgroundIL‐6 in inflammation, immunity, and disease
Tanaka, T., Narazaki, M., & Kishimoto, T. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016295 · Cited by 5,046
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769 · cited 1×
“Chronic inflammation represents the primary source of metabolic disorders promoting the onset of insulin resistance [1,2], atherosclerosis [3], neurodegenerative and cardiovascular disease (CVD) [4], obesity and cancer [5,6].”
BackgroundInflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Inflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176 · cited 2×
“Adiponectin activity is mediated by the receptors, AdipoR1 and AdipoR2 [119] which are essential in the regulation of inflammation and insulin sensitivity [120].”
BackgroundAdiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824 · cited 1×
“Adiponectin level is low in obese subjects [125] in particular high molecular weight (HMW) adiponectin which is determinant in the development of obesity and linked to insulin resistance [120] and to the incidence of type-2 diabetes [126].”
Background
Cited by
Lifestyle interventions for the prevention and treatment of hypertension
Valenzuela, P. L., Carrera-Bastos, P., Gálvez, B. G., Ruiz-Hurtado, G., Ordovas, J. M., Ruilope, L. M., & Lucia, A. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00437-9 · Cited by 354
Kenđel Jovanović, G., Mrakovcic-Sutic, I., Pavičić Žeželj, S., Šuša, B., Rahelić, D., & Klobučar Majanović, S. (2020) · Nutrients · doi:10.3390/nu12113583 · Cited by 73
“In the present study, the biomarkers of inflammation were significantly reduced in both groups, similarly or slightly greater in comparison to some other studies that evaluated the impact of diet on markers of inflammation [78,79].”
InfluentialLane, M., Howland, G., West, M., Hockey, M., Marx, W., Loughman, A., O’Hely, M., Jacka, F., & Rocks, T. (2020) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2020.04.006 · Cited by 50
Ezzati, A., Rosenkranz, S. K., Phelan, J., & Logan, C. (2023) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2022.09.013 · Cited by 45
Metadata
- Authors
- Bianchi, V. E.
- Venue
- Clinical Nutrition ESPEN
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 28
- Pages
- 21-35
- ISSN
- 2405-4577 (ISSN-L)
- OpenAlex
- W2890416444
- Cited by
- 134
- References
- 63
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Weight loss is a critical factor to reduce inflammation. https://app.cochat.ai/papers/10.1016/j.clnesp.2018.08.007
- The paper
- Bianchi, V. E. (2018). Weight loss is a critical factor to reduce inflammation. Clinical Nutrition ESPEN. https://doi.org/10.1016/j.clnesp.2018.08.007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.